Skip to main content
Menu

Hovione

Home Go up
  • Products and Services
      • Contract Manufacturing Services
        • Drug Substance
        • Particle Engineering
        • Drug Product
        • Meet the team
      • Off-patent API products
        • API Portfolio
        • Exclusive partnerships
        • High value applications
        • Performance API for Inhalation
        • Meet the team
      • Proprietary Product Licensing
        • Proprietary Product Portfolio
        • Partnering Opportunities
      • Supporting Capabilities
        • Analytical Support
        • Capabilities
        • Continuity of Supply
        • Quality and Compliance
  • Knowledge Center
  • About Hovione
  • Press Room
  • Hovione Worldwide
  • Careers
  • .co.jp
  • Restricted Area

Knowledge Center

Type

  • Articles (1) Apply Article filter

Authors

  • (-) Remove Gary L. Monks filter Gary L. Monks
  • (-) Remove Ivan Villax filter Ivan Villax
  • (-) Remove Philip Page filter Philip Page
  • Brian Heaton (1) Apply Brian Heaton filter
  • Indira Ghatak (1) Apply Indira Ghatak filter
  • Michael Hursthouse (1) Apply Michael Hursthouse filter
  • Richard Somerville (1) Apply Richard Somerville filter
  • William Heggie (1) Apply William Heggie filter

Publish date

  • 1996 (1) Apply 1996 filter
View
Article / 1996

Preparation, crystal structure and mechanism of formation of a novel dinuclear carbopentazane complex, [Rh2(PPh3)4{(NH2NH)2CH2}][NO3]2

J. Chem. Soc., Dalton Trans. (1996), (1), 61-7
Analytical Support
Quality and Compliance
Capabilities
Continuity of Supply
Track Record/cGMP Compliance
Regulatory Affairs
Continuity of Supply

© 2018 Hovione

  • Privacy Policy
  • Terms and Conditions
  • Hovione Worldwide
  • Press Room
  • Careers
  • Customers
  • Suppliers
Contacts
Sete Casas
2674 – 506 Loures, Portugal
Tel: +351 21 982 9000
Fax: +351 21 982 9388
contact@hovione.com

© 2018 Hovione

  • Privacy Policy
  • Terms and Conditions
  • Twitter
  • Linkedin
  • Facebook
  • Youtube

Contact us